Immune Globulin Subcutaneous (Human) (Vivaglobin)
Immune Globulin Subcutaneous (Human) is an FDA-licensed reference biologic from CSL Behring GmbH. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2006
Reference approved
Reference product
Vivaglobin Immune Globulin Subcutaneous (Human)
CSL Behring GmbH
- Approved
- Jan 09, 2006
- Marketing
- Disc
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Immune Globulin Subcutaneous (Human), in chronological order.
Reference approval
Approval date of the reference Immune Globulin Subcutaneous (Human) product.
20 yr 8 mo ago
Frequently asked questions
Are there biosimilars approved for Immune Globulin Subcutaneous (Human) (Vivaglobin)?
No 351(k) biosimilars or interchangeable biosimilars referencing Immune Globulin Subcutaneous (Human) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.